Portuguese | English





Pressione Enter para iniciar a Busca.





Volume 113, Nº 2, August 2019

   

DOI: http://www.dx.doi.org/10.5935/abc.20190120

ORIGINAL ARTICLE

High Level of Lipoprotein(a) as Predictor for Recurrent Heart Failure in Patients with Chronic Heart Failure: a Cohort Study

Jianlong Yan

Yanbin Pan

Junhui Xiao

Wenxue Ma

Li Li

Mingjiang Zhong

Haiquan Long

Fanliang Kong

Wenming Shao



Abstract

Background: Elevated plasma levels of Lipoprotein(a) [Lp(a)] are recognized as a significant risk factor for atherosclerotic vascular disease. However, there are limited data regarding association between Lp(a) and recurrent heart failure (HF) in patients with chronic HF caused by coronary heart disease (CHD).

Objective: Elevated levels of Lp(a) might have a prognostic impact on recurrent HF in patients with chronic HF caused by CHD.

Methods: A total of 309 patients with chronic HF caused by CHD were consecutively enrolled in this study. The patients were divided into 2 groups according to whether Lp(a) levels were above or below the median level for the entire cohort (20.6 mg/dL): the high Lp(a) group (n = 155) and the low Lp(a) group (n = 154). A 2-sided p < 0.05 was statistically considered significant.

Results: During the median follow-up period of 186 days, 31 cases out of a total of 309 patients (10.03%) could not be reached during follow-up. A Kaplan–Meier analysis demonstrated that patients with higher Lp(a) levels had a higher incidence of recurrent HF than those with lower Lp(a) levels (log-rank < 0.0001). A multivariate Cox regression analysis revealed that Lp(a) levels were independently correlated with the incidence of recurrent HF after adjustment of potential confounders (hazard ratio: 2.720, 95 % confidence interval: 1.730-4.277, p < 0.0001).

Conclusions: In Chinese patients with chronic HF caused by CHD, elevated levels of Lp(a) are independently associated with recurrent HF. (Arq Bras Cardiol. 2019; 113(2):197-204)

Keywords: Lipoproteins; Apolipoproteins; Heart Failure; Coronary Artery Disease; Hypertension; Diabetes Mellitus; Echocardiography/methods; Cohort Studies.